Antibacterial intravenous injection suite

Abstract

An intravenous administration kit is disclosed. The intravenous administration kit comprises: a fluid container containing a drug and having a discharge port on a proximal end of the fluid container; a patient access tip having an access port on a distal end and a proximal end configured to be inserted into a patient; a tube having a distal end coupled to the discharge port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source that emits light along the tube toward the patient access tip.

Description

Technical Field

[0001] The present disclosure relates generally to an IV pump kit and, in some embodiments, to an antimicrobial IV pump kit. Summary of the invention

[0002] The disclosed subject matter relates to an antimicrobial intravenous drug delivery kit. In certain embodiments, the intravenous drug delivery kit includes: a fluid container containing a drug and having an outlet port on a proximal end of the fluid container; a patient access tip having an inlet port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the outlet port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source that emits light along the tubing toward the patient access tip.

[0003] In some embodiments, light is emitted through the tubing. In some embodiments, light is transmitted via a fiber optic filament. In some embodiments, the fiber optic filament comprises polystyrene. In some embodiments, the fiber optic filament extends from the pump to the patient access tip. In some embodiments, the fiber optic filament extends partially from the pump to the patient access tip. In some embodiments, light is emitted via an optical connection. In some embodiments, light is transmitted through a lumen of the tubing. In some embodiments, light is transmitted through a wall of the tubing. In some embodiments, a light source is disposed in the pump. In some embodiments, light travels in a proximal direction from the pump toward the patient access tip.

[0004] In some embodiments, the light has antimicrobial properties. In some embodiments, the light is indigo light. In some embodiments, the indigo light has a wavelength of about 405 nm in the visible spectrum. In some embodiments, the light source continuously emits light. In some embodiments, the fluid container and the patient access tip are in fluid communication via tubing. In some embodiments, the pump is coupled to tubing closer to the fluid container than the patient access tip.

[0005] In certain embodiments, an intravenous administration kit includes: a fluid container containing a drug and having an outlet port on a proximal end of the fluid container; a patient access tip having an entry port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the outlet port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source that emits light along the tubing toward the patient access tip, wherein the light is emitted through the tubing and wherein the light has antimicrobial properties.

[0006] In some embodiments, the light is transmitted via optical fiber filaments. In some embodiments, the light is indigo light. BRIEF DESCRIPTION OF THE DRAWINGS

[0007] The foregoing summary, as well as the following detailed description of the antimicrobial IV kit, will be better understood when read in conjunction with the appended drawings of exemplary embodiments. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown.

[0008] In the attached figure:

[0009] Figure 1 A patient receiving an infusion of a medical fluid using an IV pump is described.

[0010] Figure 2 is a side view of an IV set according to an exemplary embodiment of the present disclosure.

[0011] Figure 3 is a side view of an IV pump with an optional window according to an exemplary embodiment of the present disclosure.

[0012] Figure 4 is a top view of an IV set and patient access tip according to an exemplary embodiment of the present disclosure. DETAILED DESCRIPTION

[0013] The detailed description set forth below is intended to be a description of the various configurations of the subject technology, and is not intended to represent the unique configuration that can practice the subject technology. The specific embodiments include specific details for the purpose of providing a thorough understanding of the subject technology. However, it is clear to those skilled in the art that the subject technology can be implemented without these specific details. In some cases, well-known structures and components are shown in block diagram form to avoid blurring the concept of the subject technology. For ease of understanding, identical components are marked with identical element numbers. Reference numerals may be appended with letter suffixes to indicate the individual instances of common elements, while common elements are generally referred to by the same numerals without suffix letters.

[0014] Although the following description relates to the administration of medical fluids using the peristaltic pump of the present disclosure, it should be understood that the description is merely an example of use and does not limit the scope of the claims. The various aspects of the peristaltic pump of the present disclosure can be used in any application requiring the administration of a fluid flow.

[0015] Figure 1A patient 5 is described who receives an infusion of a medical fluid using an IV pump 30. In the depicted example, the IV pump 30 delivers the medical fluid from a fluid container 36 to the patient 5. The fluid container 36 is suspended at or above the patient's head and is connected to an IV pump module 34 via an IV set 20, and then to the patient 5. In some embodiments, the IV pump 30 includes a control unit 32 and a pumping module 34. Suitable IV pump configurations and systems are described, for example, in U.S. Patent Application No. 17 / 586,619, the entire disclosure of which is incorporated herein by reference.

[0016] The pumping module 34 may include a peristaltic pump to administer the medical fluid from the fluid container 36 to the patient 5. During operation of the peristaltic pump, it may be desirable to monitor the volume pumped by the peristaltic pump. As described in more detail below, in some applications, the peristaltic pump may include an antimicrobial function.

[0017] like Figure 1 As shown, IV set 20 includes a fluid container 36, a patient access tip 38, tubing 40, IV pump 30, and a light source 42 ( Figure 2 ). Note that in the context of the present disclosure, the terms "distal" and "proximal" are used with reference to a position relative to the patient 5. The fluid container 36 may contain a medical fluid (e.g., saline solution or liquid medication) for intravenous administration. The fluid container 36 may be rigid, such as Figure 1 36, or may alternatively be a flexible bag containing medical fluid. Fluid container 36 includes an outlet 44 at its proximal end. Exit 44 may be a generally circular member extending through the proximal end of fluid container 36. Exit 44 may have a diaphragm (not shown) extending across to prevent medical fluid from passing therethrough. Exit 44 may have an inner or outer surface configured to allow other components to be coupled thereto, as described in more detail below.

[0018] The tubing 40 may be a plastic or rubber capable of conveying medical fluid therethrough. The tubing 40 may have sufficient rigidity to maintain a generally cylindrical shape when no external forces act thereon. However, the tubing 40 may be flexible enough to bend and change its cross-section in response to forces acting thereon, such as by a pump as described in more detail below.

[0019] like Figure 2 As shown, the tube 40 can have a distal end 40a and a proximal end 40b. The distal end of the tube 40 can be configured to be coupled to the discharge port 44. The distal end of the tube 40 can include threads or protrusions that are received by corresponding threads or recesses of the discharge port 44. In this way, the discharge port 44 and the tube 40 can be coupled by threads, snap fits, adhesives, welding, or any other suitable form of coupling for a particular application.

[0020] The proximal end of the tubing 40 can be coupled to the distal end of the patient access tip 38. The patient access tip 38 can have an access port on its distal end. The distal end of the access tip 38 can include threads or protrusions that are received by corresponding threads or recesses of the tubing 40. As such, the outlet port 44 and the tubing 40 can be coupled by threads, a snap fit, an adhesive, a weld, or any other suitable form of coupling for a particular application.

[0021] The patient access tip 38 has a proximal end that is configured to be inserted into the patient 5 during administration of the medical fluid. The proximal end can be a needle of a size and shape suitable for delivering the medical fluid at a desired rate. The proximal end can be a 17-gauge needle, a 18-gauge needle, a 19-gauge needle, a 20-gauge needle, a 21-gauge needle, a 22-gauge needle, a 23-gauge needle, a 24-gauge needle, a 25-gauge needle, a 26-gauge needle, a 27-gauge needle, a 28-gauge needle, a 29-gauge needle, or a 30-gauge needle. In some embodiments, the fluid container 36 and the patient access tip 38 are fluidically connected by a tubing 40.

[0022] The IV pump 30 may be coupled to tubing 40 between the fluid container 36 and the patient access tip 38. Figure 1 As shown, IV pump 30 may be coupled to tubing 40 closer to fluid container 36 than patient access tip 38. IV pump 30 may include internal components that engage tubing 40 to manipulate the cross-section so that the flow of medical fluids may be modulated and controlled depending on the specific application of IV set 20.

[0023] like Figure 2 As shown, the light source 42 can emit light along the tubing 40 toward the patient access tip 38. In some embodiments, the light has antimicrobial properties. For example, the light can kill pathogens. This can reduce bacterial colonization of the patient access site during the administration of medical fluids. The light can be indigo light. The indigo light can have a wavelength in the visible spectrum of at least 405nm. In some embodiments, the indigo light has a wavelength in the visible spectrum of approximately 405nm, 415nm, 425nm, 435nm, 445nm, or 450nm. In some embodiments, the indigo light has a wavelength in the visible spectrum between 405nm and 425nm, 410nm and 420nm, 405nm and 450nm, 415nm and 440nm, and 425nm and 430nm. In some embodiments, the light source 42 emits light continuously. In some embodiments, the light source 42 emits light intermittently.

[0024] The application of light can reduce bacterial colonization without the need to introduce potentially harsh chemicals or other antimicrobial treatments, and can avoid the use of expensive silver or platinum-based materials that have natural disinfecting properties. This can increase catheter dwell time, allowing the IV set 20 to administer more medical fluids per use and reduce the number of insertions. In addition, unlike other commonly used lights in this space (e.g., UV-based systems), indigo light is harmless to the human eye. A description of the use of indigo light that has been shown to be effective against antimicrobial resistant organisms can be found at least in U.S. Patent No. 9,039,966, the entire contents of which are incorporated herein by reference.

[0025] Light can be emitted by the light source 42 through the tubing 40. In some embodiments, the light is transmitted via a fiber optic filament 46. The fiber optic filament 46 can be disposed within the tubing 40, secured to the interior wall of the tubing 40, embedded in the wall of the tubing 40, or secured to the exterior wall of the tubing 40, or any combination thereof. The fiber optic filament 46 can include a suitable material for transmitting light emitted from the light source 42, such as polystyrene. The fiber optic filament 46 can extend from the IV pump 30 to the patient access tip 38. In some embodiments, the fiber optic filament 46 extends partially from the IV pump 30 to the patient access tip 38. The fiber optic filament 46 can terminate at a depth where infection is most likely to occur, or at a most clinically advantageous depth that balances maximum catheter flexibility with antimicrobial efficacy.

[0026] like Figure 3 As shown, a light source 42 can be disposed in the IV pump 30. In some embodiments, light can be transmitted via an optical connector 48. The optical connector 48 can be disposed between the fluid container 36 and the patient access tip 38 and can transmit light toward the patient access tip. The optical connector 48 can include a body having an inlet 50 and an outlet 52. The inlet 50 can receive a proximal end of a first segment of the tubing 40, and the outlet 52 can receive a distal end of a second segment of the tubing 40 to allow medical fluid to flow therethrough. The optical connector can transmit light through the second portion of the tubing 40 (e.g., within or within the inner wall of the tubing 40) in any manner discussed above in conjunction with the optical fiber filament 46. In some embodiments, light can be transmitted via an optical lumen (not shown) extending along the tubing 40. In some embodiments, light can be transmitted via a wall of the tubing 40 (not shown).

[0027] For example, according to the various aspects described below, the subject technology is shown. For convenience, various examples of various aspects of the subject technology are described below. These are provided only as examples and do not limit the subject technology.

[0028] An intravenous drug administration kit includes: a fluid container containing a drug and having an outlet port on a proximal end of the fluid container; a patient access tip having an entry port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the outlet port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source that emits light along the tubing toward the patient access tip.

[0029] Wherein, the light is emitted through the tube.

[0030] Therein, the light is transmitted via optical fiber filaments.

[0031] Wherein, the optical fiber filament comprises polystyrene.

[0032] Wherein the fiber optic filament extends from the pump to the patient access tip.

[0033] wherein the fiber optic filament extends partially from the pump to the patient access tip.

[0034] The light is emitted via an optical connection.

[0035] Wherein, the light is transmitted through the lumen of the tube.

[0036] Therein, the light is transmitted through the wall of the tube.

[0037] Wherein, the light source is arranged in the pump.

[0038] Therein, the light travels in a proximal direction from the pump toward the patient access tip.

[0039] Wherein the light has antibacterial properties.

[0040] Wherein, the light is indigo light.

[0041] The indigo light has a wavelength of about 405 nm in the visible spectrum.

[0042] Wherein, the light source continuously emits light.

[0043] Wherein, the fluid container and the patient access tip are in fluid communication via the tubing.

[0044] Wherein the pump is coupled to a tube that is closer to the fluid container than the patient access tip.

[0045] An intravenous drug administration kit includes: a fluid container containing a drug and having an outlet port on a proximal end thereof; a patient access tip having an entry port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the outlet port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source emitting light along the tubing toward the patient access tip, wherein the light is emitted through the tubing and wherein the light has antimicrobial properties.

[0046] Therein, the light is transmitted via optical fiber filaments.

[0047] Wherein, the light is indigo light.

[0048] In some embodiments, any one of the clauses herein can be dependent on any one of the independent clauses or any one of the dependent clauses. In one aspect, any one of the clauses (e.g., dependent clauses or independent clauses) can be combined with any other one or more clauses (e.g., dependent clauses or independent clauses). In one aspect, the claim may include some or all of the words (e.g., steps, operations, means or parts) narrated in a clause, sentence, phrase or paragraph. In one aspect, the claim may include some or all of the words narrated in one or more clauses, sentences, phrases or paragraphs. In one aspect, some of the words in each of the clauses, sentences, phrases or paragraphs can be removed. In one aspect, additional words or elements can be added to clauses, sentences, phrases or paragraphs. In one aspect, the subject technology can be implemented without utilizing some of the parts, elements, functions or operations described herein. In one aspect, the subject technology can be implemented utilizing additional parts, elements, functions or operations.

[0049] The present disclosure is provided to enable those skilled in the art to practice the various aspects described herein. The present disclosure provides various examples of the subject technology, and the subject technology is not limited to these examples. Multiple modifications to these aspects are very clear to those skilled in the art, and the general principles defined herein can be applied to other aspects.

[0050] Unless otherwise specified, reference to an element in the singular is not intended to mean "one and only one," but rather "one or more." Unless otherwise specified, the term "some" refers to one or more. Pronouns in the masculine (e.g., his) include the feminine and neuter genders (e.g., her and its) and vice versa. Headings and subheadings, if any, are used for convenience only and do not limit the disclosure.

[0051] The word "exemplary" is used herein to mean "serving as an example or illustration." Any aspect or design described herein as "exemplary" is not necessarily to be construed as preferred or advantageous over other aspects or designs. In one aspect, the various alternative configurations and operations described herein may be considered to be at least equivalent.

[0052] Phrases such as "aspects" do not mean that such aspects are essential to the subject technology, or that such aspects apply to all configurations of the subject technology. The disclosure associated with an aspect may apply to all configurations or one or more configurations. An aspect may provide one or more examples. Phrases such as "an aspect" may refer to one or more aspects, and vice versa. Phrases such as "embodiments" do not mean that such embodiments are essential to the subject technology, or that such embodiments apply to all configurations of the subject technology. The disclosure associated with an embodiment may apply to all embodiments or one or more embodiments. An embodiment may provide one or more examples. Phrases such as "an embodiment" may refer to one or more embodiments, and vice versa. Phrases such as "constructions" do not mean that such constructions are essential to the subject technology, or that such constructions apply to all configurations of the subject technology. The disclosure associated with a construction may apply to all configurations or one or more constructions. A construction may provide one or more examples. Phrases such constructions may refer to one or more constructions, and vice versa.

[0053] In one aspect, unless otherwise indicated, all measurements, values, ratings, positions, sizes, dimensions, and other specifications in this specification, including those set forth in the appended claims, are approximate and not exact. In one aspect, they are intended to have a reasonable range consistent with the functions to which they are related and with the customary practices in the art to which they belong.

[0054] In one aspect, the term "coupled" or the like may refer to a direct coupling. In another aspect, the term "coupled" or the like may refer to an indirect coupling.

[0055] Terms such as "top", "bottom", "front", "rear", etc. used in this disclosure should be understood to refer to an arbitrary reference frame other than the common gravitational reference frame. Thus, the top surface, bottom surface, front surface, and rear surface may extend upward, downward, diagonally, or horizontally in the gravitational reference frame.

[0056] Without departing from the scope of the subject technology, various items may be arranged differently (e.g., arranged in a different order, or divided in a different manner). All structural and functional equivalents of the elements of the various aspects described throughout the present disclosure are known to or will be known to those of ordinary skill in the art in the future, and are expressly incorporated herein by reference and are intended to be covered by the claims. In addition, regardless of whether such disclosure is explicitly stated in the claims, the content disclosed herein is not intended to be committed to the public. Under the provisions of the sixth paragraph of 35 U.S.C. §112, the elements of the claims will not be interpreted unless the phrase "means" is used to clearly state the element, or in the case of a method claim, the phrase "step for..." is used to state the element. In addition, for the scope of the terms "including", "having", etc. used, such terms are intended to be inclusive in a manner similar to the term "including", as explained when "including" is used as a transitional word in the claims.

[0057] The title, background technology, content of the invention, description of the drawings and abstract of the present disclosure are incorporated into the present disclosure and are provided as illustrative examples of the present disclosure, rather than restrictive descriptions. The application is submitted based on the understanding that they will not be used to limit the scope or meaning of the claims. In addition, in the specific implementation, it can be seen that the description provides illustrative examples, and in order to simplify the present disclosure, various features are combined together in various embodiments. The disclosure method should not be interpreted as reflecting the intention that the subject matter claimed for protection requires more features than those explicitly stated in each claim. On the contrary, as reflected in the attached claims, the subject matter of the invention lies in less than all features of a single disclosed construction or operation. The attached claims are therefore incorporated into the detailed description, and each claim is independently a subject matter claimed separately. The claims are not intended to be limited to the aspects described herein, but to conform to the full scope consistent with the language claims, and include all legal equivalents. Nevertheless, no claim is intended to include a subject matter that fails to meet the requirements of 35 U.S.C. §101, 102 or 103, nor should they be interpreted in this way.

Claims

1. An intravenous injection drug delivery kit, comprising: a fluid container containing a medicament and having an outlet port on a proximal end of the fluid container; a patient access tip having an access port on a distal end and a proximal end configured to be inserted into a patient; a tube having a distal end coupled to the outlet port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid reservoir and the patient access tip; and A light source emits light along the tube toward the patient access tip.

2. The intravenous drug administration kit according to claim 1, wherein: The light is emitted through the tube.

3. The intravenous drug administration kit according to claim 2, wherein: The light is transmitted via optical fiber filaments.

4. The intravenous drug administration kit according to claim 3, wherein: The optical fiber filaments include polystyrene.

5. The intravenous drug administration kit according to claim 3, wherein: The fiber optic filaments extend from the pump to the patient access tip.

6. The intravenous drug administration kit according to claim 3, wherein: The fiber optic filament extends partially from the pump to the patient access tip.

7. The intravenous drug administration kit according to claim 2, wherein: The light is emitted via an optical connection.

8. The intravenous drug administration kit according to claim 2, wherein: The light is transmitted through the lumen of the tube.

9. The intravenous drug administration kit according to claim 2, wherein: The light is transmitted through the walls of the tube.

10. The intravenous drug administration kit according to claim 1, wherein: The light source is disposed in the pump.

11. The intravenous drug administration kit according to claim 10, wherein: The light travels in a proximal direction from the pump toward the patient access tip.

12. The intravenous drug administration kit according to claim 1, wherein: The light has antimicrobial properties.

13. The intravenous drug administration kit according to claim 12, wherein: The light is indigo light.

14. The intravenous drug administration kit according to claim 13, wherein: The indigo light has a wavelength of approximately 405 nm in the visible spectrum.

15. The intravenous drug administration kit according to claim 1, wherein: The light source continuously emits light.

16. The intravenous drug administration kit according to claim 1, wherein: The fluid container and the patient access tip are in fluid communication via the tubing.

17. The intravenous drug administration kit according to claim 1, wherein: The pump is coupled to the tubing closer to the fluid container than the patient access tip.

18. An intravenous drug administration kit, the kit comprising: a fluid container containing a medicament and having an outlet port on a proximal end of the fluid container; a patient access tip having an access port on a distal end and a proximal end configured to be inserted into a patient; a tube having a distal end coupled to the outlet port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid reservoir and the patient access tip; and a light source that emits light along the tube toward the patient-accessible tip, wherein the light is emitted through the tube, and Wherein the light has antibacterial properties.

19. The intravenous drug administration kit according to claim 18, wherein: The light is transmitted via optical fiber filaments.

20. The intravenous administration kit according to claim 18, wherein: The light is indigo light.

Images